140 related articles for article (PubMed ID: 34274395)
1. Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 Oct; 163():242-243. PubMed ID: 34274395
[No Abstract] [Full Text] [Related]
2. Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
Baiocchi JMT; Fischer-Sgrott F; Baiocchi G
Radiother Oncol; 2021 Oct; 163():240-241. PubMed ID: 34274394
[No Abstract] [Full Text] [Related]
3. Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 Aug; 161():255-256. PubMed ID: 34119590
[No Abstract] [Full Text] [Related]
4. Letter to the editor regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" by Robijns et al. Radiat Oncol. 2021.
Donnelly O; Goranova R; Nugent M
Radiother Oncol; 2021 Aug; 161():254. PubMed ID: 34144079
[No Abstract] [Full Text] [Related]
5. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 May; 158():268-275. PubMed ID: 33711412
[TBL] [Abstract][Full Text] [Related]
6. Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by He et al.
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2022 Apr; 169():143-144. PubMed ID: 35065145
[No Abstract] [Full Text] [Related]
7. New photobiomodulation device for prevention and cure of radiotherapy-induced oral mucositis and dermatitis: results of the prospective Safe PBM study.
Bensadoun RJ; Bollet MA; Liem X; Cao K; Magné N
Support Care Cancer; 2022 Feb; 30(2):1569-1577. PubMed ID: 34537889
[TBL] [Abstract][Full Text] [Related]
8. Photobiomodulation therapy for the prevention of acute radiation dermatitis: a systematic review and meta-analysis.
Gobbo M; Rico V; Marta GN; Caini S; Ryan Wolf J; van den Hurk C; Beveridge M; Lam H; Bonomo P; Chow E; Behroozian T
Support Care Cancer; 2023 Mar; 31(4):227. PubMed ID: 36952036
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.
Rades D; Narvaez CA; Doemer C; Janssen S; Olbrich D; Tvilsted S; Conde-Moreno AJ; Cacicedo J
Trials; 2020 May; 21(1):424. PubMed ID: 32450921
[TBL] [Abstract][Full Text] [Related]
10. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis.
Aguiar BRL; Guerra ENS; Normando AGC; Martins CC; Reis PEDD; Ferreira EB
Crit Rev Oncol Hematol; 2021 Jun; 162():103349. PubMed ID: 33989768
[TBL] [Abstract][Full Text] [Related]
12. Topical Prevention of Radiation Dermatitis in Head and Neck Cancer Patients: A Network Meta-analysis.
Kao YS; Ma KS; Wu MY; Wu YC; Tu YK; Hung CH
In Vivo; 2022; 36(3):1453-1460. PubMed ID: 35478163
[TBL] [Abstract][Full Text] [Related]
13. Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (ARD) in head and neck cancer patients (DERMISHEAD trial)".
He J; Qian L; Gao J
Radiother Oncol; 2022 Apr; 169():142. PubMed ID: 35065148
[No Abstract] [Full Text] [Related]
14. Gel of chamomile vs. urea cream to prevent acute radiation dermatitis in patients with head and neck cancer: a randomized controlled trial.
Ferreira EB; Ciol MA; Vasques CI; Bontempo Pde S; Vieira NN; Silva LF; Avelino SR; Dos Santos MA; Dos Reis PE
J Adv Nurs; 2016 Aug; 72(8):1926-34. PubMed ID: 27020698
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of photobiomodulation therapy for the prevention of radiodermatitis: a single-institution pilot study.
Park JH; Byun HJ; Lee JH; Kim H; Noh JM; Kim CR; Oh D
Lasers Med Sci; 2020 Jul; 35(5):1119-1127. PubMed ID: 31811498
[TBL] [Abstract][Full Text] [Related]
16. The use of ambiphilic dermatological cream and radiation dermatitis in radiation therapy: a clinical study at Siriraj hospital, Bangkok.
Tepmongkol P; Chuthasri S; Rodprasert T; Rattanapol P; Maneenil W
J Med Assoc Thai; 1981 Jul; 64(7):328-32. PubMed ID: 6792312
[No Abstract] [Full Text] [Related]
17. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.
Villavicencio M; Granados-García M; Vilajosana E; Domínguez-Cherit J
Int J Dermatol; 2017 Jun; 56(6):602-609. PubMed ID: 28247918
[TBL] [Abstract][Full Text] [Related]
18. DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis.
Zenda S; Ishi S; Akimoto T; Arahira S; Motegi A; Tahara M; Hayashi R; Asanuma C
Jpn J Clin Oncol; 2015 May; 45(5):433-8. PubMed ID: 25673153
[TBL] [Abstract][Full Text] [Related]
19. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).
Rades D; Narvaez CA; Splettstößer L; Dömer C; Setter C; Idel C; Ribbat-Idel J; Perner S; Bartscht T; Olbrich D; Schild SE; Carl J
Radiother Oncol; 2019 Oct; 139():79-82. PubMed ID: 31431372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
